Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biomol Screen
2012 Feb 01;172:204-15. doi: 10.1177/1087057111421667.
Show Gene links
Show Anatomy links
Virtual screening against acetylcholine binding protein.
Utsintong M
,
Rojsanga P
,
Ho KY
,
Talley TT
,
Olson AJ
,
Matsumoto K
,
Vajragupta O
.
???displayArticle.abstract???
The nicotinic acetylcholine receptors (nAChRs) are a member of the ligand-gated ion channel family and play a key role in the transfer of information across neurological networks. The X-ray crystal structure of agonist-bound α(7) acetylcholine binding protein (AChBP) has been recognized as the most appropriate template to model the ligand-binding domain of nAChR for studying the molecular mechanism of the receptor-ligand interactions. Virtual screening of the National Cancer Institute diversity set, a library of 1990 compounds with nonredundant pharmacophore profiles, using AutoDock against AChBPs revealed 51 potential candidates. In vitro radioligand competition assays using [(3)H] epibatidine against the AChBPs from the freshwater snails, Lymnaea stagnalis, and from the marine species, Aplysia californica and the mutant (AcY55W), revealed seven compounds from the list of candidates that had micromolar to nanomolar affinities for the AChBPs. Further investigation on α(7)nAChR expressing in Xenopus oocytes and on the recombinant receptors with fluorescence resonance energy transfer (FRET)-based calcium sensor expressing in HEK cells showed that seven compounds were antagonists of α(7)nAChR, only one compound (NSC34352) demonstrated partial agonistic effect at low dose (10 µM), and two compounds (NSC36369 and NSC34352) were selective antagonists on α(7)nAchR with moderate potency. These hits serve as novel templates/scaffolds for development of more potent and specific in the AChR systems.
Arias,
Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis.
2009, Pubmed
Arias,
Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis.
2009,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Celie,
Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors.
2005,
Pubmed
Celie,
Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures.
2004,
Pubmed
Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed
Dziewczapolski,
Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease.
2009,
Pubmed
Fischer,
Selective modulation of neuronal nicotinic acetylcholine receptor channel subunits by Go-protein subunits.
2005,
Pubmed
Galzi,
Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis.
1991,
Pubmed
,
Xenbase
Grassi,
Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.
2003,
Pubmed
,
Xenbase
Hansen,
Structural and ligand recognition characteristics of an acetylcholine-binding protein from Aplysia californica.
2004,
Pubmed
Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed
Hibbs,
Acrylodan-conjugated cysteine side chains reveal conformational state and ligand site locations of the acetylcholine-binding protein.
2004,
Pubmed
Hibbs,
Influence of agonists and antagonists on the segmental motion of residues near the agonist binding pocket of the acetylcholine-binding protein.
2006,
Pubmed
Hogg,
Nicotinic acetylcholine receptors: from structure to brain function.
2003,
Pubmed
Hopkins,
Ligand efficiency: a useful metric for lead selection.
2004,
Pubmed
Jensen,
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
2005,
Pubmed
Kalamida,
Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity.
2007,
Pubmed
Kawashima,
Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function.
2004,
Pubmed
Kem,
The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
2000,
Pubmed
Kempsill,
Agonist activation and alpha-bungarotoxin inhibition of wild type and mutant alpha7 nicotinic acetylcholine receptors.
1999,
Pubmed
,
Xenbase
Kool,
High-resolution bioactivity profiling of mixtures toward the acetylcholine binding protein using a nanofractionation spotter technology.
2011,
Pubmed
Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed
Lyford,
Agonist-induced conformational changes in the extracellular domain of alpha 7 nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Malysz,
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
2010,
Pubmed
,
Xenbase
Nagele,
Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
2002,
Pubmed
Paleari,
Inhibition of non-neuronal alpha7-nicotinic receptor reduces tumorigenicity in A549 NSCLC xenografts.
2009,
Pubmed
Paleari,
Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation.
2008,
Pubmed
Papke,
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
2002,
Pubmed
,
Xenbase
Paterson,
Neuronal nicotinic receptors in the human brain.
2000,
Pubmed
,
Xenbase
Puzzo,
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus.
2008,
Pubmed
Racké,
The airway cholinergic system: physiology and pharmacology.
2004,
Pubmed
Smit,
A glia-derived acetylcholine-binding protein that modulates synaptic transmission.
2001,
Pubmed
Song,
Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma.
2003,
Pubmed
Suto,
Neuronal nicotinic acetylcholine receptors as drug targets.
2004,
Pubmed
Talley,
Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions.
2006,
Pubmed
Trombino,
Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway.
2004,
Pubmed
Ulens,
Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
2009,
Pubmed
,
Xenbase
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Vicens,
Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice.
2011,
Pubmed
Wallace,
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents.
2011,
Pubmed
,
Xenbase
Yamauchi,
Characterizing ligand-gated ion channel receptors with genetically encoded Ca2++ sensors.
2011,
Pubmed
Yu,
Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.
2011,
Pubmed
